Search

Your search keyword '"Mouscadet JF"' showing total 102 results

Search Constraints

Start Over You searched for: Author "Mouscadet JF" Remove constraint Author: "Mouscadet JF" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
102 results on '"Mouscadet JF"'

Search Results

1. Pyridoxine hydroxamic acids as novel HIV-integrase inhibitors.

2. Biochemical properties of the xenotropic murine leukemia virus-related virus integrase.

3. Impact of the Ku complex on HIV-1 expression and latency.

4. A protein ballet around the viral genome orchestrated by HIV-1 reverse transcriptase leads to an architectural switch: from nucleocapsid-condensed RNA to Vpr-bridged DNA.

5. 3' self-inactivating long terminal repeat inserts for the modulation of transgene expression from lentiviral vectors.

6. In Silico and In Vitro Comparison of HIV-1 Subtypes B and CRF02_AG Integrases Susceptibility to Integrase Strand Transfer Inhibitors.

7. Extracellular ATP acts on P2Y2 purinergic receptors to facilitate HIV-1 infection.

8. G140S/Q148R and N155H mutations render HIV-2 Integrase resistant to raltegravir whereas Y143C does not.

9. Ethyl malonate amides: a diketo acid offspring fragment for HIV integrase inhibition.

10. Synthesis, biological evaluation and molecular modeling studies of quinolonyl diketo acid derivatives: new structural insight into the HIV-1 integrase inhibition.

11. Structure-Activity Relationship Studies of HIV-1 Integrase Oligonucleotide Inhibitors.

12. Hot spots of integrase genotypic changes leading to HIV-2 resistance to raltegravir.

13. Long-lasting persistence of integrase resistance mutations in HIV-2-infected patients after raltegravir withdrawal.

14. Resistance to HIV-1 integrase inhibitors: A structural perspective.

15. New 2-arylnaphthalenediols and triol inhibitors of HIV-1 integrase--discovery of a new polyhydroxylated antiviral agent.

16. A cooperative and specific DNA-binding mode of HIV-1 integrase depends on the nature of the metallic cofactor and involves the zinc-containing N-terminal domain.

17. Chemistry and structure-activity relationship of the styrylquinoline-type HIV integrase inhibitors.

18. Impact of Y143 HIV-1 integrase mutations on resistance to raltegravir in vitro and in vivo.

19. Synthesis and anti-HIV-1 integrase activity of modified dinucleotides.

20. Raltegravir: molecular basis of its mechanism of action.

21. HIV-1 IN alternative molecular recognition of DNA induced by raltegravir resistance mutations.

22. Structural and theoretical studies of [6-bromo-1-(4-fluorophenylmethyl)-4(1H)-quinolinon-3-yl)]-4-hydroxy-2-oxo-3-butenoïc acid as HIV-1 integrase inhibitor.

23. Structural basis for HIV-1 DNA integration in the human genome, role of the LEDGF/P75 cofactor.

24. Quasispecies variant dynamics during emergence of resistance to raltegravir in HIV-1-infected patients.

25. The G140S mutation in HIV integrases from raltegravir-resistant patients rescues catalytic defect due to the resistance Q148H mutation.

26. Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02_AG subtypes.

27. Design, synthesis, and biological evaluation of a series of 2-hydroxyisoquinoline-1,3(2H,4H)-diones as dual inhibitors of human immunodeficiency virus type 1 integrase and the reverse transcriptase RNase H domain.

28. Integrase and integration: biochemical activities of HIV-1 integrase.

29. Insight into the integrase-DNA recognition mechanism. A specific DNA-binding mode revealed by an enzymatically labeled integrase.

30. The total synthesis of fukiic acid, an HIV-1 integrase inhibitor.

31. Synthesis and antiviral properties of some polyphenols related to Salvia genus.

32. Synthesis and biological activities of a series of 4,5-diaryl-3-hydroxy-2(5H)-furanones.

33. Structural effects of amino acid variations between B and CRF02-AG HIV-1 integrases.

34. Reaction of rosmarinic acid with nitrite ions in acidic conditions: discovery of nitro- and dinitrorosmarinic acids as new anti-HIV-1 agents.

35. Mutations associated with failure of raltegravir treatment affect integrase sensitivity to the inhibitor in vitro.

36. Synthesis and HIV-1 integrase inhibition of novel bis- or tetra-coumarin analogues.

37. Ku80 participates in the targeting of retroviral transgenes to the chromatin of CHO cells.

38. Efficient and specific internal cleavage of a retroviral palindromic DNA sequence by tetrameric HIV-1 integrase.

39. Target recognition by catechols and beta-ketoenols: potential contribution of hydrogen bonding and Mn/Mg chelation to HIV-1 integrase inhibition.

40. Simple criterion for selection of flavonoid compounds with anti-HIV activity.

41. Investigation of novel lipid-functionalized PNA monomers as potential HIV-1 non-nucleoside reverse transcriptase and/or integrase inhibitors.

42. Comparative molecular surface analysis (CoMSA) for virtual combinatorial library screening of styrylquinoline HIV-1 blocking agents.

43. The engagement of activating FcgammaRs inhibits primate lentivirus replication in human macrophages.

44. Inhibition of early steps of HIV-1 replication by SNF5/Ini1.

45. Relationship between the oligomeric status of HIV-1 integrase on DNA and enzymatic activity.

46. HIV-1 integrase inhibition of biscoumarin analogues.

47. Design, synthesis, and anti-integrase activity of catechol-DKA hybrids.

48. Probing of HIV-1 integrase/DNA interactions using novel analogs of viral DNA.

49. Kinetic study of the HIV-1 DNA 3'-end processing.

50. Intermolecular interactions in the crystal structures of potential HIV-1 integrase inhibitors.

Catalog

Books, media, physical & digital resources